Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Furukawa

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 7, 2021
[Epigenetic abnormalities in non-Hodgkin lymphomas]Yusuke Furukawa
Leukemia & Lymphoma|May 10, 2002
Cell cycle control genes and hematopoietic cell differentiationYusuke Furukawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[Treatment strategies for multiple myeloma based on molecular pathogenesis]Yusuke Furukawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2020
[Toll-like receptor CD180 and the bone marrow microenvironment as therapeutic targets in multiple myeloma]Jiro Kikuchi, Yusuke Furukawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[The mechanisms of drug resistance via the interaction of myeloma cells with stromal cells]Jiro Kikuchi, Yusuke Furukawa
International Journal of Hematology|June 1, 2004
Alterations of common chromosome fragile sites in hematopoietic malignanciesHideshi Ishii, Yusuke Furukawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[DNA methyltransferase inhibitors * histone deacetylase inhibitors]Jiro Kikuchi, Yusuke Furukawa
International Journal of Clinical Oncology|May 9, 2015
Molecular pathogenesis of multiple myelomaYusuke Furukawa, Jiro Kikuchi
International Journal of Hematology|February 7, 2020
Molecular basis of clonal evolution in multiple myelomaYusuke Furukawa, Jiro Kikuchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 7, 2016
Epigenetic regulation of cell adhesion-mediated drug resistance acquisition in multiple myelomaYusuke Furukawa, Jiro Kikuchi
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 7, 2021
[Epigenetic abnormalities in non-Hodgkin lymphomas]Yusuke Furukawa
Leukemia & Lymphoma|May 10, 2002
Cell cycle control genes and hematopoietic cell differentiationYusuke Furukawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[Treatment strategies for multiple myeloma based on molecular pathogenesis]Yusuke Furukawa
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2020
[Toll-like receptor CD180 and the bone marrow microenvironment as therapeutic targets in multiple myeloma]Jiro Kikuchi, Yusuke Furukawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[The mechanisms of drug resistance via the interaction of myeloma cells with stromal cells]Jiro Kikuchi, Yusuke Furukawa
International Journal of Hematology|June 1, 2004
Alterations of common chromosome fragile sites in hematopoietic malignanciesHideshi Ishii, Yusuke Furukawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[DNA methyltransferase inhibitors * histone deacetylase inhibitors]Jiro Kikuchi, Yusuke Furukawa
International Journal of Clinical Oncology|May 9, 2015
Molecular pathogenesis of multiple myelomaYusuke Furukawa, Jiro Kikuchi
International Journal of Hematology|February 7, 2020
Molecular basis of clonal evolution in multiple myelomaYusuke Furukawa, Jiro Kikuchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 7, 2016
Epigenetic regulation of cell adhesion-mediated drug resistance acquisition in multiple myelomaYusuke Furukawa, Jiro Kikuchi
Pageof 12